Unit | Depression (N = 106) | Healthy controls (N = 106) | Relative mean difference (95% CI) | p-values | |||
---|---|---|---|---|---|---|---|
N > LLOD | Mean (95% CI) | N > LLOD | Mean (95% CI) | ||||
IL-6 | 10–12 g/mL | 106 | 0.90 (0.81–0.99) | 106 | 0.81 (0.73–0.89) | 1.10 (0.93–1.30) | 0.276 |
IL-8 | 10–12 g/mL | 106 | 17.69 (16.71–18.72) | 106 | 20.40 (19.27–21.59) | 1.05 (0.96–1.16) | 0.294 |
IFN-γa | 10–12 g/mL | 92 | 0.26 (0.22–0.29) | 67 | 0.16 (0.13–0.18) | 1.04 (0.82–1.31) | 0.762 |
IL-1αa,b | 10–14 g/mL | 13 | 0.36 (0.05–2.66) | 9 | 0.21 (0.02–1.79) | 1.13 (0.18–7.26) | 0.899 |
IL-1βa | 10–14 g/mL | 18 | 0.05 (0.01–0.22) | 8 | 0.02 (0.00–0.10) | 3.52 (0.92 -13.45) | 0.066 |
IL-2a,b | 10–14 g/mL | 28 | 1.11 (0.70–1.76) | 15 | 0.75 (0.43–1.29) | 1.49 (0.92–2.41) | 0.105 |
IL-4a,b | 10–14 g/mL | 69 | 1.28 (1.12–1.48) | 40 | 0.92 (0.78–1.08) | 1.40 (1.14–1.72) | 0.001c |
IL-5a | 10–12 g/mL | 71 | 0.50 (0.42–0.59) | 74 | 0.55 (0.46–0.65) | 0.84 (0.64–1.12) | 0.236 |
IL-7a | 10–12 g/mL | 93 | 0.56 (0.49–0.63) | 99 | 0.66 (0.59–0.75) | 0.90 (0.73–1.12) | 0.345 |
IL-10a | 10–14 g/mL | 87 | 8.44 (7.41–9.61) | 71 | 7.11 (6.19–8.16) | 1.04 (0.84–1.31) | 0.700 |
IL-12a,d | 10–12 g/mL | 104 | 5.19 (4.69–5.74) | 105 | 4.76 (4.30–5.27) | 0.98 (0.82–1.16) | 0.792 |
IL-13a | 10–12 g/mL | 12 | 1.11 (0.94–1.32) | 18 | 1.20 (1.04–1.39) | 0.98 (0.84–1.15) | 0.803 |
IL-15 | 10–12 g/mL | 106 | 3.13 (2.90–3.37) | 106 | 3.24 (3.01–3.49) | 0.95 (0.84–1.08) | 0.454 |
IL-16 | 10–12 g/mL | 106 | 9.60 (8.75–10.54) | 106 | 11.02 (10.04–12.10) | 0.89 (0.76–1.05) | 0.164 |
IL-17Aa,b | 10–13 g/mL | 15 | 0.95 (0.27–3.34) | 10 | 0.83 (0.21–3.34) | 1.15 (0.40–3.29) | 0.795 |
IP-10a | 10–11 g/mL | 106 | 9.08 (8.04–10.24) | 105 | 9.15 (8.11–10.33) | 1.15 (0.93–1.41) | 0.191 |
MCP-1a | 10–10 g/mL | 106 | 3.38 (3.07–3.73) | 105 | 3.12 (2.83–3.44) | 1.25 (1.06–1.47) | 0.009e |
MCP-4a,b | 10–11 g/mL | 5 | 1.35 (0.74–2.46) | 2 | 1.13 (0.54–2.35) | 1.20 (0.85–1.70) | 0.310 |
MDCa | 10–12 g/mL | 94 | 7.35 (6.61–8.17) | 92 | 7.81 (7.02–8.68) | 0.94 (0.78–1.13) | 0.497 |
MIP-1αa | 10–12 g/mL | 68 | 2.72 (2.46–3.02) | 82 | 3.53 (3.20–3.90) | 0.87 (0.73–1.03) | 0.103 |
MIP-1βa | 10–12 g/mL | 106 | 9.54 (8.83–10.31) | 105 | 9.00 (8.33–9.72) | 1.16 (1.02–1.33) | 0.025e |
TARCa | 10–12 g/mL | 59 | 1.94 (1.69–2.22) | 65 | 2.18 (1.91–2.49) | 1.07 (0.86–1.33) | 0.559 |
TNF-αa | 10–13 g/mL | 26 | 1.06 (0.70–1.59) | 34 | 1.36 (0.92–2.02) | 0.74 (0.44–1.25) | 0.266 |
TNF-βa | 10–14 g/mL | 7 | 0.15 (0.01–2.00) | 8 | 0.29 (0.02–3.34) | 0.31 (0.04–2.29) | 0.251 |
ICAM-1 | 10–9 g/mL | 106 | 1.48 (1.40–1.57) | 106 | 1.41 (1.33–1.50) | 1.04 (0.94–1.16) | 0.401 |